Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients

Trial N/A Completed March 29, 2017

Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

Trial Phase 4 Completed March 29, 2017

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics

Trial Phase 1 Completed March 29, 2017

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

Trial Phase 4 Completed March 28, 2017

Effect of Food on BIA 6-512 (Trans-resveratrol)

Trial Phase 1 Completed March 28, 2017

Tolerability and Steady-state Pharmacokinetics of BIA 6-512

Trial Phase 1 Completed March 27, 2017

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease

Trial Phase 1 Completed March 26, 2017

Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics

Trial Phase 1 Completed March 26, 2017

Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics

Trial Phase 1 Completed March 26, 2017

Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease

Trial Phase 1 Completed March 23, 2017

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

Trial Phase 3 Completed March 22, 2017

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Trial Phase 3 Completed March 22, 2017

Caffeine as a Therapy for Parkinson's Disease

Trial Phase 3 Completed March 21, 2017

A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease

Trial Phase 1 Completed March 20, 2017

Variable Frequency Stimulation of Subthalamic Nucleus for Freezing of Gait in Parkinson's Disease

Trial Phase 1 Completed March 20, 2017

Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment

Trial N/A Completed March 16, 2017

Dance Exercise as Novel Complementary Therapy for Parkinson's Disease

Trial N/A Completed March 15, 2017

Extended Long-Term Safety Study of KW-6500

Trial Phase 3 Completed March 14, 2017

Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease

Trial Phase 3 Completed March 14, 2017

Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease

Trial Phase 4 Completed March 9, 2017